COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 489: Articles 4881-4890  | Next

Risks of digestive diseases in long COVID: Evidence from a large-scale cohort study
Ma, Y., Zhang, L., Wei, R., Dai, W., Zeng, R., Luo, D., Jiang, R., Wu, H., Zhuo, Z., Yang, Q., Li, J., Leung, F. W., Duan, C., Sha, W., Chen, H.
10.1101/2023.04.25.23289080 — Posted: 2023-04-25
Using extracted data from Kaplan-Meier curves to compare COVID-19 vaccine efficacy
Tansawet, A.
10.1101/2023.04.19.23288799 — Posted: 2023-04-25
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Springer, D. N., Bauer, M., Medits, I., Camp, J. V., Aberle, S. W., Burtscher, C., Hoeltl, E., Weseslindtner, L., Stiasny, K., Aberle, J. H.
10.1101/2023.04.20.23288813 — Posted: 2023-04-25
SARS-CoV-2 Spike Protein Reduces Burst Activities in Neurons Measured by Micro-Electrode Arrays
Salvador, M., Tseng, N., Park, C., Williams, G., Vethan, A., Thomas, G., Baker, J., Hemry, J., Hammond, E., Freeburg, P., Chou, G.-W., Taylor, N., Lu, Y.-F.
10.1101/2023.04.24.538161 — Posted: 2023-04-25
How Do Deer Respiratory Epithelial Cells Weather The Initial Storm of SARS-CoV-2?
Davila, K. M. S., Nelli, R. K., Phadke, K. S., Ruden, R. M., Sang, Y., Bellaire, B. H., Gimenez-Lirola, L. G., Miller, L. C.
10.1101/2023.04.24.538130 — Posted: 2023-04-25
Racial disparities, environmental exposures, and SARS-CoV-2 infection rates: A racial map study in the USA
Xu, W., Jiang, B., Webster, C., Sullivan, W. C., Lu, Y., Chen, N., Yu, Z., Chen, B.
10.1101/2023.04.17.23288622 — Posted: 2023-04-24
Deprivation effect on COVID-19 cases incidence and severity: a geo-epidemiological study in PACA region, France
Gaubert, G., Nauleau, S., Franke, F., Rebeaudet, S., Mosnier, E., Landier, J., Chaud, P., Malfait, P., Vandentorren, S., Huart, M., Ramdani, A., Bendiane, M.-k., Danjou, F., Gaudart, J.
10.1101/2023.04.18.23288723 — Posted: 2023-04-24
Changes in hospital staff mental health during the Covid-19 pandemic: longitudinal results from the international COPE-CORONA study
Lanzara, R., Conti, C., Rosa, I., Pawłowski, T., Malecka, M., Rymaszewska, J., Porcelli, P., Stein, B., Waller, C., Müller, M. M., Members of the Cope-Corona Study Group
10.1101/2023.04.20.23288855 — Posted: 2023-04-24
LONG-TERM PHYSICAL AND MENTAL HEALTH IMPACT OF COVID-19 ON ADULTS IN ENGLAND: FOLLOW UP OF A LARGE RANDOM COMMUNITY SAMPLE
Atchison, C. J., Davies, B., Cooper, E., Lound, A., Whitaker, M., Hampshire, A., Azor, A., Donnelly, C. A., Chadeau-Hyam, M., Cooke, G., Ward, H., Elliott, P.
10.1101/2023.04.24.23289043 — Posted: 2023-04-24
The Brazilian COVID-19 vaccination campaign: A modelling analysis of socio-demographic factors on uptake
Li, S. L., Prete, C. A., Zarebski, A. E., de Souza Santos, A. A., Sabino, E. C., Nascimento, V. H., Wu, C.-H., Messina, J. P.
10.1101/2023.04.21.23288730 — Posted: 2023-04-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).